Condition: Frontotemporal Lobar Degeneration · Alzheimer Disease · Cognitively Normal · Sponsor: University of Pennsylvania
The investigators will compare \[18F\]-PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's disease (naAD), and demographically matched cognitively normal subjects.
This description comes directly from the study's public registry record.
David J Irwin, MD · 215-662-3361 · dirwin@pennmedicine.upenn.edu
Jeffrey S Phillips, PhD · 215-349-5863 · jefphi@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| Perelman Center for Advance Medicine | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05456503